{"doi":"10.1016/0960-894x(96)00323-x","title":"Sildenafil (VIAGRATM), a potent and selective inhibitor of type 5 cGMP phosphodiesterase with utility for the treatment of male erectile dysfunction","abstract":null,"journal":"Bioorganic & Medicinal Chemistry Letters","year":1996,"id":26655,"datarank":21.40072369216949,"base_score":6.406879986069314,"endowment":6.406879986069314,"self_citation_contribution":0.9610319979103973,"citation_network_contribution":20.439691694259093,"self_endowment_contribution":0.9610319979103973,"citer_contribution":20.439691694259093,"corpus_percentile":null,"corpus_rank":null,"citation_count":605,"citer_count":200,"citers_with_citation_signal":200,"citers_with_endowment":200,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":153721,"name":"Andrew S. Bell","orcid":null,"position":1,"is_corresponding":false},{"id":153722,"name":"David Brown","orcid":null,"position":2,"is_corresponding":false},{"id":20010,"name":"Peter Ellis","orcid":"0000-0003-1590-2130","position":3,"is_corresponding":false},{"id":153720,"name":"Nicholas K. Terrett","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"base_score":6.406879986069314,"endowment":6.406879986069314,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"18998881","pmcid":null,"openalex_id":"https://openalex.org/W2110010969","authors":[],"funders":[],"total_grants":0,"fwci":6.6476,"citation_percentile":0.97337137,"influential_citations":5,"citation_trend":[{"year":2012,"count":27},{"year":2013,"count":33},{"year":2014,"count":31},{"year":2015,"count":27},{"year":2016,"count":53},{"year":2017,"count":25},{"year":2018,"count":24},{"year":2019,"count":24},{"year":2020,"count":31},{"year":2021,"count":41},{"year":2022,"count":21},{"year":2023,"count":18},{"year":2024,"count":22},{"year":2025,"count":9},{"year":2026,"count":3}],"oa_status":"closed","license":"https://www.elsevier.com/tdm/userlicense/1.0/","oa_locations":[{"url":"https://api.elsevier.com/content/article/PII:0960894X9600323X?httpAccept=text/xml","host_type":"publisher"},{"url":"https://api.elsevier.com/content/article/PII:0960894X9600323X?httpAccept=text/plain","host_type":"publisher"},{"url":"https://doi.org/10.1016/0960-894x(96)00323-x","host_type":"journal"}],"fields_of_study":["Sexual function and dysfunction studies","Hormonal and reproductive studies","Pharmacological Effects and Toxicity Studies","Chemistry","Medicine"],"mesh_terms":[],"keywords":["Sildenafil","Erectile dysfunction","cGMP-specific phosphodiesterase type 5","Phosphodiesterase","Chemistry","Pharmacology","Enzyme inhibitor","Phosphodiesterase inhibitor","Tadalafil","Internal medicine","Endocrinology","Medicine","Enzyme","Biochemistry"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-06-08T15:09:17.524094Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}